Drugmakers Fall After White House Ends Drug-Rebate Overhaul Push

Jul.11 — The White House abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers, a move that could turn scrutiny back on how drugmakers themselves set prices. Bloomberg’s Anna Edney reports on “Bloomberg Markets: The Close.”